bq-123 and Glomerulosclerosis--Focal-Segmental

bq-123 has been researched along with Glomerulosclerosis--Focal-Segmental* in 1 studies

Other Studies

1 other study(ies) available for bq-123 and Glomerulosclerosis--Focal-Segmental

Article	Year
Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Endothelin Receptor Antagonists; Glomerulosclerosis, Focal Segmental; Heart Rate; Humans; Kidney Failure, Chronic; Peptides, Cyclic; Proteinuria; Renin-Angiotensin System; Treatment Outcome	2009

Article

Year

Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease.

Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3

Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Endothelin Receptor Antagonists; Glomerulosclerosis, Focal Segmental; Heart Rate; Humans; Kidney Failure, Chronic; Peptides, Cyclic; Proteinuria; Renin-Angiotensin System; Treatment Outcome

2009